Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations

Molecular and Cellular Biology

Volumn 25, Issue 14, 2005, Pages 6065-6076

  Compe, Emmanuel ^a   Drané, Pascal ^a   Laurent, Camille ^a   Diderich, Karin ^b   Braun, Cathy ^a   Hoeijmakers, Jan H J ^b   Egly, Jean Marc ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 7; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; RNA POLYMERASE II; TRANSCRIPTION FACTOR IIH;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION; XERODERMA PIGMENTOSUM;

ADIPOSE TISSUE; ANIMALS; DNA HELICASES; DNA-BINDING PROTEINS; LIVER; MICE; MICE, MUTANT STRAINS; MUTATION; PHOSPHORYLATION; PPAR ALPHA; PPAR GAMMA; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR TFIIH; TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS, TFII; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 21744438445     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.14.6065-6076.2005     Document Type: Article

References (49)

1. Adams, M., M. J. Reginato, D. Shao, M. A. Lazar, and V. K. Chatterjee. 1997. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128-5132.
2. Akoulitchev, S., S. Chuikov, and D. Reinberg. 2000. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407:102-106.
3. Auwerx, J. 1999. PPARγ, the ultimate thrifty gene. Diabetologia 42:1033-1049.
4. Berger, J., and D. E. Moller. 2002. The mechanisms of action of PPARs. Annu. Rev. Med. 53:409-435.
5. Bootsma, D., and J. H. J. Hoeijmakers. 1993. DNA repair. Engagement with transcription. Nature 363:114-115.
6. Botta, E., T. Nardo, B. C. Broughton, S. Marinoni, A. R. Lehmann, and M. Stefanini. 1998. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. Am. J. Hum. Genet. 63:1036-1048.
7. Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J. M. Egly, and S. Ali. 2000. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6:127-137.
8. Cherkaoui-Malki, M., K. Meyer, W. Q. Cao, N. Latruffe, A. V. Yeldandi, M. S. Rao, C. A. Bradfield, and J. K. Reddy. 2001. Identification of novel peroxisome proliferator-activated receptor alpha (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene. Expr. 9:291-304.
9. Coin, F., J. C. Marinoni, C. Rodolfo, S. Fribourg, A. M. Pedrini, and J. M. Egly. 1998. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat. Genet. 20:184-188.
10. de Boer, J., J. de Wit, H. van Steeg, R. J. Berg, H. Morreau, P. Visser, A. R. Lehmann, M. Duran, J. H. Hoeijmakers, and G. Weeda. 1998. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell 1:981-990.
11. Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649-688.
12. Drane, P., E. Compe, P. Catez, P. Chymkowitch, and J. M. Egly. 2004. Selective regulation of vitamin D receptor-responsive genes by TFIIH. Mol. Cell 16:187-197.
13. Dubaele, S., L. Proietti De Santis, R. Bienstock, A. Keriel, M. Stefanini, B. Van Houten, and J. Egly. 2003. Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol. Cell 11:1635-1646.
14. Grosschedl, R. 1995. Higher-order nucleoprotein complexes in transcription: analogies with site-specific recombination. Curr. Opin. Cell Biol. 7:362-370.
15. Happle, R., H. Traupe, H. Grobe, and G. Bonsmann. 1984. The Tay syndrome (congenital ichthyosis with trichothiodystrophy). Eur. J. Pediatr. 141:147-152.
16. He, W., Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, M. Nelson, E. Ong, J. M. Olefsky, and R. M. Evans. 2003. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100:15712-15717.
17. Hengartner, C. J., V. E. Myer, S. M. Liao, C. J. Wilson, S. S. Koh, and R. A. Young. 1998. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell 2:43-53.
18. Holstege, F. C., P. C. van der Vliet, and H. T. Timmers. 1996. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. EMBO J. 15:1666-1677.
19. Hu, E., J. B. Kim, P. Sarraf, and B. M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100-2103.
20. Humbert, S., H. van Vuuren, Y. Lutz, J. H. J. Hoeijmakers, J. M. Egly, and V. Moncollin. 1994. p44 and p34 subunits of the BTF2/TFIIH transcription factor have homologies with SSL, a yeast protein involved in DNA repair. EMBO J. 13:2393-2398.
21. Itin, P. H., and M. R. Pittelkow. 1990. Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias. J. Am. Acad. Dermatol. 22:705-717.
22. Johnson, R. T., S. Squires, G. C. Ellion, G. L. E. Koch, and A. J. Rainbow. 1985. Xeroderma pigmentosum D-HeLa hybrids with low and high ultraviolet sensitivity associated with normal and diminished DNA repair ability, respectively. J. Cell Sci. 76:115-133.
23. Juge-Aubry, C. E., E. Hammar, C. Siegrist-Kaiser, A. Pernin, A. Takeshita, W. W. Chin, A. G. Burger, and C. A. Meier. 1999. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274:10505-10510.
24. Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, et al. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
25. Keriel, A., A. Stary, A. Sarasin, C. Rochette-Egly, and J. M. Egly. 2002. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell 109:125-135.
26. Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature 405:421-424.
27. Kopecky, J., Z. Hodny, M. Rossmeisl, I. Syrovy, and L. P. Kozak. 1996. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am. J. Physiol. 270:E768-E775.
28. Lee, C. H., P. Olson, and R. M. Evans. 2003. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201-2207.
29. Lehmann, A. R. 2001. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 15:15-23.
30. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ). J. Biol. Chem. 270:12953-12956.
31. 3-dependent cell-free transcription. Mol. Cell. Biol. 17:1923-1937.
32. Lu, H., L. Zawel, L. Fisher, J. M. Egly, and D. Reinberg. 1992. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358:641-645.
33. Mascaro, C., E. Acosta, J. A. Ortiz, P. F. Marrero, F. G. Hegardt, and D. Haro. 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273:8560-8563.
34. Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M. L. Reitman, and C. Vinson. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168-3181.
35. Reddy, J. K., and T. Hashimoto. 2001. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21:193-230.
36. Rickert, P., J. L. Corden, and E. Lees. 1999. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18:1093-1102.
37. Riedl, T., F. Hanaoka, and J. Egly. 2003. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J. 22:5293-5303.
38. Rochette-Egly, C., S. Adam, M. Rossignol, J. M. Egly, and P. Chambon. 1997. Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90:97-107.
39. Rosen, E. D., P. Sarraf, A. E. Troy, G. Bradwin, K. Moore, D. S. Milstone, B. M. Spiegelman, and R. M. Mortensen. 1999. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4:611-617.
40. Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J. P. Tassan, L. Schaeffer, J. H. J. Hoeijmakers, and J. M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093-1101.
41. Sandrock, B., and J. M. Egly. 2001. A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH. J. Biol. Chem. 276:35328-35333.
42. Sears, I. B., M. A. MacGinnitie, L. G. Kovacs, and R. A. Graves. 1996. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 16:3410-3419.
43. Shimomura, I., R. E. Hammer, J. A. Richardson, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12:3182-3194.
44. Taylor, E. M., B. C. Broughton, E. Botta, M. Stefanini, A. Sarasin, N. G. Jaspers, H. Fawcett, S. A. Harcourt, C. F. Arlett, and A. R. Lehmann. 1997. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl. Acad. Sci. USA 94:8658-8663.
45. Tirode, F., D. Busso, F. Coin, and J. M. Egly. 1999. Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7. Mol. Cell 3:87-95.
46. Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156.
47. van Steeg, H., and K. H. Kraemer. 1999. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol. Med. Today 5:86-94.
48. Wang, Y. X., C. H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159-170.
49. Zurita, M., and C. Merino. 2003. The transcriptional complexity of the TFIIH complex. Trends Genet. 19:578-584.